Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-008668
Filing Date
2018-02-14
Accepted
2018-02-14 13:56:09
Documents
1
Group Members
GARY J. MORGENTHALERGARY R. LITTLEJOHN LUTSIMORGENTHALER MANAGEMENT PARTNERS VIII, LLCRALPH E. CHRISTOFFERSENROBERT C. BELLAS, JR.ROBERT D. PAVEY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv486071_sc13da.htm SC 13D/A 109386
  Complete submission text file 0001144204-18-008668.txt   111095
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 18610663
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 PUBLIC SQUARE STE 2700 CLEVELAND OH 44113
Business Address 50 PUBLIC SQUARE STE 2700 CLEVELAND OH 44113
Morgenthaler Partners VIII LP (Filed by) CIK: 0001352701 (see all company filings)

EIN.: 000000000
Type: SC 13D/A